ELIZABETH BONDS: Open Payments
NPI 1609318070 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,756 in 93 payments from 27 companies in 2025. Trend: 2023 $1,497 · 2024 $2,814 · 2025 $2,756
Food & beverage: $2,756
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $380 |
| AstraZeneca Pharmaceuticals LP | 13 | $326 |
| BeOne Medicines USA, Inc. | 5 | $188 |
| Caris MPI, Inc. | 4 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $170 |
| E.R. Squibb & Sons, L.L.C. | 5 | $167 |
| Novartis Pharmaceuticals Corporation | 8 | $166 |
| Stemline Therapeutics Inc. | 4 | $165 |
| Daiichi Sankyo Inc. | 8 | $161 |
| GlaxoSmithKline, LLC. | 1 | $121 |
Products named: ENHERTU, RYBREVANT, BRUKINSA, MI CANCER SEEK, OPDIVO, Orserdu, KISQALI, OJJAARA.
Industry payments across FL — which companies pay providers there.
